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Abstract
The more than 1.5 billion people who live in South Asia are correctly viewed not as a single large 
population, but as many small endogamous groups. We assembled genome-wide data from over 
2,800 individuals from over 260 distinct South Asian groups. We identify 81 unique groups, of 
which 14 have estimated census sizes of more than a million, that descend from founder events 
more extreme than those in Ashkenazi Jews and Finns, both of which have high rates of recessive 
disease due to founder events. We identify multiple examples of recessive diseases in South Asia 
that are the result of such founder events. This study highlights an under-appreciated opportunity 
for reducing disease burden among South Asians through the discovery of and testing for recessive 
disease genes.
South Asia is a region of extraordinary diversity, containing over 4,600 anthropologically 
well-defined groups many of which are endogamous communities with significant barriers 
to gene flow due to cultural practices that restrict marriage between groups1. Of the tiny 
fraction of South Asian groups that have been characterized using genome-wide data, many 
exhibit large allele frequency differences from close neighbors2–4, consistent with strong 
founder events whereby a small number of ancestors gave rise to many descendants today4. 
The pervasive founder events in South Asia present a potential opportunity for reducing 
disease burden in South Asia. The promise is highlighted by studies of founder groups of 
European ancestry – including Ashkenazi Jews, Finns, Amish, Hutterites, Sardinians, and 
French Canadians – which have resulted in the discovery of dozens of recessive disease 
causing mutations in each group. Prenatal testing for these mutations has substantially 
reduced recessive disease burden in all of these communities5,6.
We carried out new genotyping of 1,663 samples from 230 endogamous groups in South 
Asia on the Affymetrix Human Origins single nucleotide polymorphism (SNP) array7. We 
combined the data we newly collected with previously reported data, leading to four datasets 
(Figure 1a). The Affymetrix Human Origins SNP array data comprised 1,955 individuals 
from 249 groups in South Asia, to which we added 7 Ashkenazi Jews. The Affymetrix 6.0 
SNP array data comprised 383 individuals from 52 groups in South Asia4,8. The Illumina 
SNP array data comprised 188 individuals from 21 groups in South Asia9 and 21 Ashkenazi 
Jews9,10. The Illumina Omni SNP array data comprised 367 individuals from 20 groups in 
South Asia11. We merged 1000 Genomes Phase 3 data12 (2,504 individuals from 26 different 
groups including 99 Finns) with each of these datasets. We removed SNPs and individuals 
with a high proportion of missing genotypes or that were outliers in Principal Components 
Analysis (PCA) (Figure 1b; Supplementary Text). The total number of unique groups 
analyzed in this study is 263 after accounting for groups represented in multiple datasets. To 
our knowledge, this represents the richest set of genome-wide data from anthropologically 
well-documented groups from any region in the world.
We devised an algorithm to quantify the strength of the founder events in each group based 
on Identity-by-Descent (IBD) segments, large stretches of DNA shared from a common 
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founder in the last approximately one hundred generations (Figure 2). We computed an 
“IBD score” as a measure for the strength of the founder event in each group’s history: the 
average length of IBD segments between 3–20 centimorgans (cM) shared between two 
genomes normalized to sample size. Since we are interested in characterizing the impact of 
recessive diseases that do not owe their origin to consanguineous marriages of close 
relatives, we ignored self-matches (internal homozygosity) in IBD calculations. We removed 
all individuals that had evidence of recent relatedness (within a few generations) to others in 
the dataset by computing IBD between all pairs of individuals in each group and removing 
one individual from the pairs with outlying numbers of IBD segments (our focus on founder 
events rather than recent relatedness also explains our choice to exclude IBD segments of 
greater than 20 cM in size). We validated the effectiveness of this procedure by simulation 
(Supplementary Table 1; Online Methods).
We expressed IBD scores for each group as a fraction of the IBD scores of the 1000 
Genomes Project Finns merged into each respective dataset. Due to the fact that all the SNP 
arrays we analyzed included more SNPs ascertained in Europeans than in South Asians, the 
sensitivity of our methods to founder events is greater in Europeans than in South Asians, 
and thus our estimates of founder event strengths in South Asian groups are conservative 
underestimates relative to that in Europeans (Supplementary Figure 1 demonstrates this 
effect empirically and shows that it is less of a bias for the strong founder events that are the 
focus of this study). We computed standard errors for these ratios by a weighted Block 
Jackknife across chromosomes and declared significance where the 95% confidence 
intervals did not overlap 1. We carried out computer simulations to validate our procedure. 
The simulations suggest that we are not substantially overestimating the magnitudes of 
modest founder events, since for a simulated founder event that is half the magnitude of that 
in Finns, we never infer the score to be significantly greater than in Finns. The simulations 
also suggest that our procedure is highly sensitive to detecting strong founder events, since 
for sample sizes of at least 5, the algorithm’s sensitivity is greater than 95% for determining 
that a group with two times the bottleneck strength as Finns has an IBD score significantly 
greater than that of Finns (Supplementary Figure 2 and Supplementary Table 2). We also 
used two additional non-IBD based methods to measure the strength of founder events and 
in cases where a comparison was possible found high correlation of these results with our 
IBD scores (Supplementary Text and Supplementary Table 3).
We infer that 81 out of 263 unique groups (96 out of 327 groups if not considering the 
overlap of groups among datasets) have an IBD score greater than those of both Finns and 
Ashkenazi Jews (Figure 3). These results did not change when we added back the outlier 
samples that we removed in quality control. A total of 14 of these groups have estimated 
census sizes of over a million (Figure 3; Table 1). However, the groups with smaller census 
sizes are also very important – outside of South Asia, small census size groups with 
extremely strong founder events such as Amish, Hutterites, and people of the Saguenay Lac-
St. Jean region have led to the discovery of dozens of novel disease causing variants. We 
also searched for IBD across groups – screening for cases in which the across-group IBD 
score is at least a third of the within-group IBD score of Ashkenazi Jews – and found 77 
cases of clear IBD-sharing, which typically follow geography, religious affiliation, or 
linguistic grouping (particularly Austroasiatic speakers) (Supplementary Table 4). Pairs of 
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groups with high shared IBD and descent from a common founder event will share risk for 
the same recessive disease. However, these cross-group IBD sharing patterns are not driving 
our observations, as we still identify 68 unique sets of groups without high IBD to other 
groups that have significantly higher estimated IBD scores than both Finns and Ashkenazi 
Jews.
Our documentation that very strong founder events affect a large fraction of South Asian 
groups presents an opportunity for decreasing disease burden in South Asia. This source of 
risk for recessive diseases is very different from that due to marriages among close relatives, 
which is also a major cause of recessive disease in South Asia. To determine the relative 
impact of these factors, we computed FST, a measurement of allele frequency differentiation, 
between each group in the dataset and a pool of other South Asian groups chosen to be 
closest in terms of ancestry proportions. We find that inbreeding is not driving many of these 
signals, as 89 unique groups have higher FST scores than those of Ashkenazi Jews and Finns 
even after reducing the FST score by the proportion of allele frequency differentiation due to 
inbreeding. These results show that while most recessive disease gene mapping studies in 
South Asia have focused on families that are the products of marriages between close 
relatives, recessive diseases are also likely to occur at an elevated rate even in non-
consanguineous cases because of shared ancestors more distantly in time.
As an example of the promise of founder event disease gene mapping in South Asia, we 
highlight the case of the Vysya, who have a census size of more than 3 million and who we 
estimate have an IBD score about 1.2-fold higher than Finns (Figure 3). The Vysya have an 
approximately 100-fold higher rate of butyrylcholinesterase deficiency than other groups, 
and Vysya ancestry is a known counter-indication for the use of muscle relaxants such as 
succinylcholine or mivacurium that are given prior to surgery13. This disease is likely to 
occur at a higher rate due to the founder event in Vysya’s history, and we expect that, like 
Finns, Vysya likely have a higher rate of many other diseases compared to other groups. 
Other examples of recessive disease genes with a likely origin in founder events are known 
anecdotally in South Asia, highlighting the importance of systematic studies to find them14.
To demonstrate how a new recessive disease in a founder event group could be mapped, we 
carried out whole genome SNP genotyping in 12 patients from southern India who had 
progressive pseudorheumatoid dysplasia (PPD), a disease known to be caused by mutations 
in the gene WISP315,16. Of the 6 individuals with the Cys78Tyr mutation in WISP3,15,16 5 
were from non-consanguineous marriages, and we found a much higher fraction of IBD at 
the disease mutation site than in the rest of the genome in these individuals (Supplementary 
Figure 3a; Supplementary Figure 4a), consistent with the Cys78Tyr mutation that causes 
PPD in these patients owing its origin to a founder event. This pattern contrasts with the 6 
other patients with different disease variants and 6 patients with a mutation causing a 
different disease (mucopolysaccharidosis (MPS) type IVA) who were from primarily 
consanguineous marriages, and who lacked significant IBD across their disease mutation 
sites, implying that in the case of these groups the driver for the recessive diseases was 
marriage between close relatives (Supplementary Text). This example highlights how not 
only marriages of close relatives, but also founder events, are substantial causes of rare 
recessive disease in South Asia.
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The evidence of widespread strong founder events presents a major opportunity for disease 
gene discovery and public health intervention in South Asia that is not widely appreciated. 
The current paradigm for recessive disease gene mapping in South Asia is to collect cases in 
tertiary medical centers and map diseases in individuals with the same phenotype, often 
blinded to information about group affiliation as in the case of the PPD study where we do 
not have access to the ethnic group information. However, our results suggest that collecting 
information on group affiliation could be greatly strengthen the power of these studies. A 
fruitful way to approach gene mapping would be to proactively survey communities known 
to have strong founder events, searching for diseases that occur at high rates in these 
communities. This approach was pioneered in the 1950s in studies of the Old Order Amish 
in the U.S., a founder population of approximately 100,000 individuals in whom many 
dozens of recessive diseases were mapped, a research program that was crucial to founding 
modern medical genetics and that was of extraordinary health benefit. Our study suggests 
that the potential for disease gene mapping in South Asia would be orders of magnitude 
greater.
Mapping of recessive diseases may be particularly important in communities practicing 
arranged marriages, which are common in South Asia. An example of the power of this 
approach is given by Dor Yeshorim, a community genetic testing program among religious 
Ashkenazi Jews17, which visits schools, screens students for common recessive disease 
causing mutations previously identified to be segregating at a higher frequency in the target 
group, and enters the results into a confidential database. Matchmakers query the database 
prior to making suggestions to the families and receive feedback about whether the potential 
couple is “incompatible” in the sense of both being carriers for a recessive mutation at the 
same gene. Given that approximately 95% of community members whose marriages are 
arranged participate in this program, recessive diseases like Tay-Sachs have virtually 
disappeared in these communities. A similar approach should work as well in South Asian 
communities. Given the potential for saving lives, this or similar kinds of research could be a 
valuable investment for future generations18.
Online Methods
Data Sets
We assembled a dataset of 1,955 individuals from 249 groups genotyped on the Affymetrix 
Human Origins array, of which data from 1,663 individuals from 230 groups are newly 
reported here (Figure 1a). We merged these data with the dataset published in Moorjani et 
al.8, which consisted of 332 individuals from 52 groups genotyped on the Affymetrix 6.0 
array. We also merged it with two additional datasets published in Metspalu et al.9, 
consisting of 151 individuals from 21 groups genotyped on Illumina 650K arrays as well as 
a dataset published in Basu et al.11, consisting of 367 individuals from 20 groups generated 
on Illumina Omni 1-Quad arrays. These groups come from India, Pakistan, Nepal, Sri 
Lanka, and Bangladesh. All samples were collected under the supervision of ethical review 
boards in India with informed consent obtained from all subjects.
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We analyzed two different Ashkenazi Jewish datasets, one consisting of 21 individuals 
genotyped on Illumina 610K and 660K bead arrays10 and one consisting of 7 individuals 
genotyped on Affymetrix Human Origins arrays.
Our “Affymetrix 6.0” dataset consists of 332 individuals genotyped on 329,261 SNPs, and 
our “Illumina_Omni” dataset consists of 367 individuals genotyped on 750,919 SNPs. We 
merged the South Asian and Ashkenazi Jewish data generated by the other Illumina arrays to 
create an “Illumina” dataset consisting of 172 individuals genotyped on 500,640 SNPs. We 
merged the data from the Affymetrix Human Origins arrays with the Ashkenazi Jewish data 
and data from the Simons Genome Diversity Project19,20 to create a dataset with 4,402 
individuals genotyped on 512,615 SNPs. We analyzed the four datasets separately due to the 
small intersection of SNPs between them. We merged in the 1000 Genomes Phase 3 data21 
(2,504 individuals from 26 different groups; notably, including 99 Finnish individuals) into 
all of the datasets. We used genome reference sequence coordinates (hg19) for analyses.
Quality Control
We filtered the data at both the SNP and individual level. On the SNP level, we required at 
least 95% genotyping completeness for each SNP (across all individuals). On the individual 
level, we required at least 95% genotyping completeness for each individual (across all 
SNPs).
To test for batch effects due to samples from the same group being genotyped on different 
array plates, we studied instances where samples from the same group A were genotyped on 
both plates 1 and 2 and computed an allele frequency difference at each SNP, 
. We then computed the product of these allele 
frequencies averaged over all SNPs for two groups A and B genotyped on the same plates, 
, as well as a standard error from a weighted Block Jackknife across 
chromosomes. This quantity should be consistent with zero within a few standard errors if 
there are no batch effects that cause systematic differences across the plates, as allele 
frequency differences between two samples of the same group should be random 
fluctuations that have nothing to do with the array plates on which they are genotyped. This 
analysis found strong batch effects associated with one array plate, and we removed these 
samples from further analysis.
We used EIGENSOFT 5.0.1 smartpca22 on each group to detect PCA outliers and removed 
51 samples. We also developed a procedure to distinguish recent relatedness from founder 
events so that we could remove recently related individuals. We first identified all duplicates 
or obvious close relatives by using Plink23 “genome” and GERMLINE24 to compute IBD 
(described in more detail below) and removed one individual from all pairs with a PI_HAT 
score greater than 0.45 and the presence of at least 1 IBD fragment greater than 30cM. We 
then used an iterative procedure to identify additional recently related individuals. For 
sample sizes above 5, we identified any pairs within each group that had both total IBD and 
total long IBD (>20cM) that were greater than 2.5 SDs and 1 SD, respectively, from the 
group mean. For sample sizes 5 or below, we used modified Z scores of 0.6745*(IBD_score 
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- median(score))/MAD, where MAD is the median absolute deviation, and identified all 
pairs with modified Z scores greater than 3.5 for both total IBD and total long IBD as 
suggested by Iglewicz and Hoaglin25. After each round, we repeated the process if the new 
IBD score was at least 30% lower than the prior IBD score. Simulations showed that we 
were always able to remove a first or second cousin in the dataset using this method 
(Supplementary Table 1). Together these analyses removed 53 individuals from the 
Affymetrix 6.0 dataset, 21 individuals from the Illumina dataset, 43 individuals from the 
Illumina Omni dataset, and 225 individuals from the Human Origins dataset.
After data quality control and merging with the 1000 Genomes Project data, the Affymetrix 
6.0 dataset included 2,842 individuals genotyped on 326,181 SNPs, the Illumina dataset 
included 2,662 individuals genotyped on 484,293 SNPs, the Illumina Omni dataset included 
2,828 individuals genotyped on 750,919 SNPs, and the Human Origins dataset included 
4,177 individuals genotyped at 499,158 SNPs.
Simulations to Test Relatedness Filtering and IBD Analyses
We used ARGON26 to simulate groups with different bottleneck strengths to test the IBD 
analyses and relatedness filtering. We used ARGON’s default settings, including a mutation 
rate of 1.65*10−8 per base pair (bp) per generation and a recombination rate of 1*10−8 per 
bp per generation and simulated 22 chromosomes of size 130 Mb each. We pruned the 
output by randomly removing SNPs until there were 22,730 SNPs per chromosome to 
simulate the approximate number of positions in the Affymetrix Human Origins array. For 
the IBD analyses, we simulated groups to have descended from an ancestral group 1,800 
years ago with Ne=50,000 and to have formed two groups with Ne=25,000. These groups 
continued separately until 100 generations ago when they combined in equal proportions to 
form a group with Ne=50,000. The group then split into 3 separate groups 72 generations 
ago that have bottlenecks leading to Ne of either 400, 800, or 1600. The 3 groups then 
exponentially expanded to a present size of Ne=50,000. We designed these simulations to 
capture important features of demographic history typical of Indian groups4,8. We chose the 
bottleneck sizes because they represent founder events with approximately the strength of 
Finns (the bottleneck to 800), and twice as strong (400) and half as strong (1600) as that 
group. We then performed the IBD analyses described below with 99 individuals from the 
group with bottleneck strength similar to that of Finns (198 haploid individuals were 
simulated and merged to produce 99 diploid individuals) and different numbers of 
individuals from the other groups. These analyses demonstrate that with only 4–5 
individuals we can accurately assess the strength of founder events in groups with strong 
founder events (Supplementary Figure 2 and Supplementary Table 2). Weaker founder 
events are more difficult to assess, but these groups are of less interest for founder event 
disease mapping, so we aimed to sample ~5 individuals per group.
We wrote custom R scripts to simulate first and second cousin pairs. We took individuals 
from the bottleneck of size 800 and performed “matings” by taking 2 individuals and 
recombining their haploid chromosomes assuming a rate of 1*10−8 per bp per generation 
across the chromosome and combining one chromosome from each of these individuals to 
form a new diploid offspring. The matings were performed to achieve first and second 
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cousins. We then placed these back into the group with group of size 800, and ran the 
relatedness filtering algorithms to evaluate whether they would identify these individuals.
Phasing, IBD Detection, and IBD Score Algorithm
We phased all datasets using Beagle 3.3.2 with the settings missing=0; lowmem=true; 
gprobs=false; verbose=true27. We left all other settings at default. We determined IBD 
segments using GERMLINE24 with the parameters -bits 75 -err_hom 0 -err_het 0 -min_m 3. 
We used the genotype extension mode to minimize the effect of any possible phasing 
heterogeneity amongst the different groups and used the HaploScore algorithm to remove 
false positive IBD fragments with the recommended genotype error and switch error 
parameters of 0.0075 and 0.00328. We chose a HaploScore threshold matrix based on 
calculations from Durand et al.28 for a “mean overlap” of 0.8, which corresponds to a 
precision of approximately 0.9 for all genetic lengths from 2–10cM. It can sometimes be 
difficult to measure IBD in admixed populations due to differential proportions of the 
divergent ancestries amongst different individuals in the same group, but we found that in 
both the simulated and real data we were able to detect IBD at the expected amounts.
In addition to the procedure we developed to remove close relatives (Quality Control 
section), we also removed segments longer than 20cM as simulations showed that this 
increased sensitivity of the analyses (Supplementary Table 2). We computed “IBD score” as 
the total length of IBD segments between 3–20cM divided by  where n is the 
number of individuals in each group to normalize for sample size. We then expressed each 
group’s score as a ratio of their IBD score to that of Finns and calculated standard errors for 
this score using a weighted Block Jackknife over each chromosome with 95% confidence 
intervals defined as IBD score ±1.96*s.e.
We repeated these analyses with FastIBD29 for the Affymetrix 6.0 and Illumina datasets and 
observed that the results were highly correlated (r>0.96) (data not shown). We chose 
GERMLINE for our main analyses, however, because the FastIBD algorithm required us to 
split the datasets into different groups, since it adapts to the relationships between LD and 
genetic distance in the data, and these relationships differ across groups. We used data from 
several different Jewish groups and all twenty-six 1000 Genomes groups to improve 
phasing, but of these groups we only included results for Ashkenazi Jews and two outbred 
groups (CEU and YRI) in the final IBD score ranking.
Disease patient analyses
We use Affymetrix Human Origins arrays to successfully genotype 12 patients with 
progressive pseudorheumatoid dysplasia (PPD) and 6 patients with mucopolysaccharidosis 
(MPS) type IVA, all of whom had disease mutations previously determined15,16,30 (3 of the 
surveyed MPS patients are newly reported here). A total of 6 of the PPD patients had 
Cys78Tyr mutations, 6 had Cys337Tyr mutations (all 6 of the MPS patients had Cys78Arg 
mutations). We measured IBD as described above and also detected homozygous segments 
within each individual by using GERMLINE with the parameters -bits 75 -err_hom 2 -
err_het 0 -min_m 0.5 -homoz-only.
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Haplotype sharing was assessed by analyzing phased genotypes for each mutation group. At 
each SNP, we counted the number of identical genotypes for each allele and computed the 
fraction by dividing by the total number of possible haplotypes (2 times the number of 
individuals). We took the larger value of the two possible alleles (thus the fraction range was 
0.5–1). We averaged these values over blocks of 10 or 25 SNPs and plotted the averages 
around the relevant mutation site.
Between-Group IBD Calculations
We determined IBD using GERMLINE as above. We collapsed individuals into respective 
groups and normalized for between-group IBD by dividing all IBD from each group by 
 where n is the number of individuals in each group. We normalized for within-
group IBD as described above. We defined groups with high shared IBD as those with an 
IBD score greater than three times the founder event strength of CEU (and ~1/3 the event 
strength of Ashkenazi Jews).
f3-statistics
We used the f3-statistic7 f3(Test; Ref1, Ref2) to determine if there was evidence that the Test 
group was derived from admixture of groups related to Ref1 and Ref2. A significantly 
negative statistic provides unambiguous evidence of mixture in the Test group. We 
determined the significance of the f3-statistic using a Block Jackknife and a block size of 5 
cM. We considered statistics over 3 standard errors below zero to be significant.
Computing Group Specific Drift
We used qpGraph7 to model each Indian group on the cline as a mixture of ANI and ASI 
ancestry, using the model (YRI, (Indian group, (Georgians, ANI)), [(ASI, Onge])) proposed 
by Moorjani et al.8 This approach provides estimates for post-admixture drift in each group 
(Supplementary Figure 5), which is reflective of the strength of the founder event (high drift 
values imply stronger founder events). We only included groups on the Indian cline in this 
analysis, and we removed all groups with evidence of East Asian related admixture (Figure 
1b and Supplementary Table 6) because this admixture is not accommodated within the 
above model.
PCA-Normalized FST Calculations
As a third method to measure strength of founder events, we estimated the minimum FST 
between each South Asian group (Supplementary Figure 6) and their closest clusters based 
on PCA (Supplementary Text) (the clusters were used to account for intermarriage across 
groups that would otherwise produce a downward bias in the minimum FST). For the 
Affymetrix 6.0, Illumina, and Illumina_Omni datasets, we split the Indian cline into two 
different clusters and combined the Austroasiatic speakers and those with ancestry related to 
Austroasiatic speakers (according to the PCA of Figure 1b) into one cluster for a total of 
three clusters (all other groups were ignored for this analysis). For the Human Origins 
dataset we split the Indian cline into three different clusters and combined the groups with 
ancestry related to the main cluster of Austroasiatic speakers into one cluster for a total of 
four clusters (Khasi and Nicobarese were ignored in this analysis, because they do not 
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cluster with the other Austroasiatic speaking groups). We then computed the FST between 
each group and the rest of the individuals in their respective cluster based on EIGENSOFT 
smartpca with Inbreed set to YES to correct for inbreeding. For Ashkenazi Jews and Finns, 
we used the minimum FST to other European groups.
FST Calculations to Determine Overlapping Groups
Overlapping groups between the datasets were determined in the first place based on 
anthropological information (Online Table 1). We further tested empirically for overlap by 
computing FST between different groups across all datasets for groups with significantly 
stronger IBD scores than those of Finns (we could not perform this analysis for groups with 
less strong founder events, because they would have low FST to each other even if they were 
truly distinct groups). We considered pairs with FST less than 0.004 to be overlapping. These 
included all groups known to be overlapping based on anthropological information as well 
as 3 additional pairs of groups that might be genetically similar due to recent mixing (e.g. 
Kanjars and Dharkar are distinct nomadic groups that live near each other but intermarry, 
leading to low FST between them).
Code Availability
Code for all calculations available upon request.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Dataset overview
(a) Sampling locations for all analyzed groups. Each point indicates a distinct group 
(random jitter was added to help in visualization at locations where there are many groups). 
(b) PCA of Human Origins dataset along with European Americans (CEU) and Han Chinese 
(CHB). There is a large cluster (blue) of IndoEuropean and Dravidian speaking groups that 
stretch out along a line in the plot and that are well-modeled as a mixture of two highly 
divergent ancestral populations (the “Indian Cline”). There is another larger cluster of 
Austroasiatic speakers (light red) and groups that cluster with them genetically (dark red). 
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Finally, there are groups with genetic affinity to East Asians that include Tibeto-Burman 
speakers (orange) and those that speak other languages (yellow).
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Figure 2. Example histograms of IBD segments to illustrate the differences between groups with 
founder events of different magnitudes
These histograms provide visual illustrations of differences between groups with different 
IBD scores. As a ratio relative to Finns (FIN; black), these groups (red) have IBD scores of: 
(A) ~26 in Ulladan, (B) ~3 in Birhor, (C) ~0.9 in Ashkenazi Jews, and (D) ~0.1 in 
Mahadeo_Koli. In each plot, we also show European Americans (CEU) with a negligible 
founder event in blue. Quantification of these founder events is shown in Figure 3 and 
Supplementary Table 5. The IBD histograms were normalized for sample size by dividing 
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their frequency by , where n is the number of individuals in the sample. All 
data for the figure are based on the Human Origins dataset.
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Figure 3. IBD scores relative to Finns (FIN)
Histogram ordered by IBD score, roughly proportional to the per-individual risk for 
recessive disease due to the founder event. (These results are also given quantitatively for 
each group in Online Table 1.) We restrict to groups with at least two samples, combining 
data from all four genotyping platforms onto one plot. Data from Ashkenazi Jews and Finns 
are highlighted in red, and from South Asian groups with significantly higher IBD scores 
than that of Finns and census sizes of more than a million in brown. Error bars for each IBD 
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score are standard errors calculated by weighted block jackknife over each chromosome. 
YRI=Yoruba (West African); CEU=European American.
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